Prospective Evaluation of New Hydrophobic Acrylic IOL
Narrative Responses:
Purpose
To evaluate visual, refractive, and safety outcomes in eyes implanted with the enVista (Bausch + Lomb) MX60 hydrophobic acrylic intraocular lens (IOL) during routine cataract surgery.
Methods
This was a prospective study of subjects implanted with the enVista IOL in one or both eyes during routine cataract surgery. Subjects (n=20 eyes) were followed postoperatively for 3 months. Examinations included refraction (manifest refraction spherical equivalent, MRSE), visual acuity, and safety.
Results
100% of eyes achieved postoperative MRSE within ±1.00 D of the target MRSE and postoperative uncorrected visual acuity of 20/40 or better. No glistenings or unexpected adverse events were reported.
Conclusion
Implantation of the MX60 IOL is a safe and effective treatment of aphakia after cataract extraction. The lens provides good visual acuity and has excellent refractive predictability.